Cancer papers

Thyroid cancer research papers

Papers tagged to Thyroid cancer. Adjust filters if you want a narrower scope.

4 papersSorted by most recent
Evaluating the Cost of Genomic Testing for Biomarker-Driven Therapies in Oncology.
Oncology and therapy • 2026-02-18 • DOI: 10.1007/s40487-026-00416-z
Peer-reviewedImpact 71

Topics

Treatment, Diagnosis, Biology / Mechanism

Modality

Targeted therapy, Biomarker / Liquid biopsy, Imaging

Study type

Not listed

Abstract

Genomic profiling is used in the diagnosis, monitoring, and treatment of malignancies. Comprehensive genomic profiling (CGP) is a next-generation sequencing (NGS) approach that can test multiple genes simultaneously, potentially saving time, money, and sample material. Costs associated with genomic profiling could be a prohibitive…

Authors

Jamie P Grossman, Elizabeth A Sheppard, Zhuofan Yan, Magdalene Crabbe +1

AI-generated summary

Evaluating the Cost of Genomic Testing for Biomarker-Driven Therapies in Oncology. reports: Genomic profiling is used in the diagnosis, monitoring, and treatment of malignancies. Comprehensive genomic profiling (CGP) is a next-generation sequencing (NGS) approach that can test multiple genes simultaneously, potentially saving time, money, and sample material. Costs associated with genomic profiling could be a prohibitive barrier to the widespread implementation of genomic testing in routine clinical practice.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Implementing a Rapid Response Pathway for Anaplastic Thyroid Cancer in a Universal Healthcare System.
Laryngoscope investigative otolaryngology • 2026-02-01 • DOI: 10.1002/lio2.70360
Peer-reviewedImpact 83

Topics

Treatment, Diagnosis, Biology / Mechanism, Outcomes / Survival

Modality

Surgery, Imaging

Study type

Early human (Phase 1/2)

Abstract

To implement a multidisciplinary anaplastic thyroid cancer rapid response team (ARRT) pathway in a universal healthcare system and evaluate its impact on diagnostic and treatment timelines for patients with anaplastic thyroid cancer (ATC). This quasi-experimental study was conducted at a tertiary care cancer center…

Authors

Sana Ghaznavi, Kiana Mahboubi, Debbie Lamb, Kara Hawker +9

AI-generated summary

Implementing a Rapid Response Pathway for Anaplastic Thyroid Cancer in a Universal Healthcare System. reports: To implement a multidisciplinary anaplastic thyroid cancer rapid response team (ARRT) pathway in a universal healthcare system and evaluate its impact on diagnostic and treatment timelines for patients with anaplastic thyroid cancer (ATC). This quasi-experimental study was conducted at a tertiary care cancer center in Canada. We compared 26 consecutive adult patients with confirmed ATC: 11 patients in the pre-pathway period (January 2015-June 2020) and 15 in the post-pathway period (July 2020-July 2023).

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Topics

Treatment, Biology / Mechanism, Prevention / Risk

Modality

Imaging

Study type

Not listed

Abstract

The temporal dynamics of sleep disturbances following radioactive iodine (RAI) therapy for differentiated thyroid cancer (DTC), along with their underlying mechanisms and associated factors, remain poorly understood. This gap underscores the need for longitudinal investigations. We conducted a longitudinal study of 160 DTC patients…

Authors

Wanmin Huang, Yusheng Zheng, Jinyan Guo, Chunliu Luo

AI-generated summary

The relationship between sleep disturbances, depression and anxiety in differentiated thyroid cancer patients during radioiodine (131I) therapy: a longitudinal observational study. reports: The temporal dynamics of sleep disturbances following radioactive iodine (RAI) therapy for differentiated thyroid cancer (DTC), along with their underlying mechanisms and associated factors, remain poorly understood. This gap underscores the need for longitudinal investigations. We conducted a longitudinal study of 160 DTC patients from Guangdong Southern Teaching Hospital.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Thyroid Cancer in Solid-Organ Transplant Recipients.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation • 2026-01-01 • DOI: 10.6002/ect.2025.0240
Peer-reviewedImpact 71

Topics

Treatment, Diagnosis, Prevention / Risk

Modality

Surgery, Imaging

Study type

Observational, Review / Meta-analysis

Abstract

One of the best treatment methods for end-stage organ failure is solid-organ transplant. Experiences gained in the postoperative treatment and follow-up of transplant recipients continue to guide the morbidity and mortality rates of patients. Evaluations regarding the increased risk of thyroid cancer after solid-organ…

Authors

Funda Salgür, Altuğ Kut, Özlem Turhan İyidir, Meriç Yavuz Çolak +1

AI-generated summary

Thyroid Cancer in Solid-Organ Transplant Recipients. reports: One of the best treatment methods for end-stage organ failure is solid-organ transplant. Experiences gained in the postoperative treatment and follow-up of transplant recipients continue to guide the morbidity and mortality rates of patients. Evaluations regarding the increased risk of thyroid cancer after solid-organ transplant are still controversial.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.